2015 World Hepatitis Day – Hep C: Testing & Monitoring Makes Sense.
The campaign we have developed for World Hepatitis Day 2015 is based on the idea that people who inject really do need to know their hep C status for a variety of reasons. Knowing their hep C Status allows people to have other tests for genotypes and other assessments while considering their options. The knowledge people gain from these tests make it possible, and can empower them, to find all the information to help them look after their health.
It makes sense to test and monitor your health when you have hep C. As new treatments become available (not yet available on the PBS), require less time, and are not nearly as brutal as earlier versions, only you will know when treatment is the right option for you. For World Hepatitis Day 2015 AIVL has designed a Campaign containing a series of print and web based posters, pop ups, email footers and website banners focusing on the importance of hep C testing and monitoring. Campaign material was developed ‘by users for users’ and aims to be direct and straight to the point by acknowledging the reality of injecting drug use and the difficulties we all face as a result of using proscribed drugs.
The AIVL World Hepatitis Day Campaign has an overarching message across all campaign material “Hep C: Testing & Monitoring Makes Sense.“ with each also including an individual targeted message. For example one web based pop up states “Your liver needs a fix! Many Australian injectors have hep C, but most don’t know what that can mean. Find out – get a liver health check.” while another declares “Being a drug user takes guts. Not getting tested for hep C takes liver”. The Campaign poster targeted at Needle & Syringe Programs (NSP) is more low key with it’s messaging, however there is nothing low key about its message “C a Future – Been injecting for awhile and still going strong? Help your liver do the same”. We are also promoting our extensive range of fact sheets for drug users who also have hepatitis C and these can be downloaded from our Hep C Fact Sheets section on the AIVL website.
You can download a copy of our Media Release for World Hepatitis Day 2015: “Hepatitis C – What Are We Waiting For?”
All of the AIVL World Hepatitis Day Campaign material can be downloaded below, or if you would like us to send you a hard copy of the print poster please contact AIVL on email@example.com or call the AIVL Office.
Note: While AIVL has utilised different methods of promoting the Campaign material (website pop ups and banners, email footers and hard copy posters) you can use them in anyway you see fit. Be creative and find other ways you can use them like why not try one of the email footers as your Facebook photo, or use the website banner as your cover photo.
2014 World Hepatitis Day – “Treatment as Prevention?” What does the future hold for injecting drug users?
Treatment as Prevention (TasP) is a new initiative being explored following its debated success with-in the HIV prevention arena. TasP raises many issues and challenges, including how we can use TasP when the current treatment model in Australia is not accessible or suitable for so many. Before we move ahead we need to consider: the willingness of governments to invest in necessary resources, increasing awareness of the chronic HCV epidemic, HCV screening and testing, the needs of affected communities, current prevention strategies, and models of HCV treatment.
Below is a recorded video of the webinar AIVL held as well as the information provided to particpants to outline the issue of treatment as prevention for injecting drug users.
- Information for participants (PDF, 2.3Mb)
2011 World Hepatitis Day – Older Opiate Users & Hepatitis Forum
To bring greater attention to this important emerging issue the Australian Injecting & Illicit Drug Users League (AIVL) held a forum in Canberra and online on Friday 29 July 2011. The forum was held as part of National Hepatitis Awareness Week 2011 and will address the health needs of older opiate users with a specific focus on hepatitis C. A panel of national experts will provide a range of perspectives on the issues of ageing, opioid use and hepatitis.
Below you’ll find a collection of relevant information from the forum;
- Watch AIVL’s Older Opiate Users & Hepatitis Forum 2011 Online
- Double Jeopardy: Older Injecting Opioid Users in Australia – AIVL Policy Paper (PDF, 995 Kb)
- Special Edition: AIVL Research & Policy Update – Older Injecting Opiate Users & Hepatitis (PDF, 725 Kb)
- AIVL Media Relaease: “Older Injecting Drug Users – We’re Alive, But Will We Survive?” (PDF, 62 Kb)
2010 World Hepatitis Awareness Week – Access to NSP
In conjunction with the Annual World Hepatitis Awareness Week, The Australian Injecting & Illicit Drug Users League (AIVL) and the NSW Users & AIDS Association (NUAA) held a launch of 2 critical discussion papers covering the following issues;
- How does legislation and policy impact on people’s access to NSP, and subsequently their right and means to protect themselves from blood borne viruses (BBV)?
- How can we overcome the legislative and policy barriers to NSP – simply and pragmatically?
The Papers that were launched at this event can be accessed below;
- Legislative and Policy Barriers to Needle & Syringe Program (NSP) Access
- Deregulation of Needle and Syringe Provision to Improve Distribution and Access to Sterile Injecting Equipment in New South Wales
2009 National Hepatitis Awareness Week:Aboriginal Discussion Panel
Every year during National Hepatitis Awareness week AIVL picks an issue that we believe needs highlighting in the IDU/HCV area, in 2008 we held a forum on NSPs/HCV in prisons. This year we are looking to hold a national forum focusing on the unacceptable high rates of HCV in the Aboriginal community.
Hepatitis C rates among all people with a history of injecting drug use are extremely high 80% of all current infection and 90% of all new infection. The level among Indigenous IDU is disproportionally and unacceptably high. Again Indigenous people appear to be bearing the brunt of this epidemic. What is the reason for this? Do we have any answers? AIVL and it’s Indigenous program plays a crucial role in working with government, community organisations and the affected communities in working towards reducing the incidence of hepatitis C and providing information and support for those who have hepatitis C.
World Hepatitis Day and National Hepatitis Awareness Week provides an excellent opportunity to highlight the issue of blood-borne viruses in the indigenous community.
Needle Exchange Programs in Australian Prisons: Making it Happen
On the 20th May 2008, AIVL hosted a forum for National Hepatitis Awareness Week at the ACT Legislative Assembly that explored the issues around introducing needle exchange programs (NEPs) into Australian prisons. The forum was fully booked, with in excess of 60 people packing a small room.
The speakers at the forum expressed a variety of viewpoints, from that of prisoners’ and corrections staff health, human rights, political considerations and the perspectives of inmates.
The speakers were:
Director, Alcohol and Drug Service, St Vincent’s Hospital Sydney
The International Evidence – what does it tells us?
Executive Director, Australian National Council on Drugs
An Australian Context – what are the next steps?
Chief Executive Officer, Public Health Association of Australia
The Political Process – how do we encourage political leadership?
ACT Human Rights and Discrimination Commissioner
Human Rights in Prisons – can prisons & rights coexist?
The ‘Real’ Experience – is there a duty of care to prisoners?
Following the talks, the speakers were joined by Deb Wyborne to form a panel which took questions from the audience.